Tandem Diabetes Care (TNDM) Cash & Equivalents Growth (3y) (2016 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Cash & Equivalents Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 32.23% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | -21.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.68% |
| Mar 31, 2026 | 11.96% |
| Dec 31, 2025 | -19.31% |
| Sep 30, 2025 | -9.44% |
| Jun 30, 2025 | -17.69% |
| Mar 31, 2025 | -17.00% |
| Dec 31, 2024 | -0.92% |
| Sep 30, 2024 | -24.15% |
| Jun 30, 2024 | -21.49% |
| Mar 31, 2024 | -21.26% |
| Dec 31, 2023 | -14.63% |
| Sep 30, 2023 | -14.97% |
| Jun 30, 2023 | -16.24% |
| Mar 31, 2023 | 19.70% |
| Dec 31, 2022 | 49.94% |
| Sep 30, 2022 | 39.03% |
| Jun 30, 2022 | 44.43% |
| Mar 31, 2022 | -9.31% |
| Dec 31, 2021 | 19.39% |
| Sep 30, 2021 | -0.36% |